BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18174522)

  • 1. Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas.
    Zhang X; Bao S; Lai D; Rapkins RW; Gillies MC
    Diabetes; 2008 Apr; 57(4):1026-33. PubMed ID: 18174522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two isoforms of Flk-1 transcripts in early diabetic rat retinas.
    Zhang X; Chen M; Gillies MC
    Curr Eye Res; 2012 Jan; 37(1):73-9. PubMed ID: 22121831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.
    Huang J; Li X; Li M; Li S; Xiao W; Chen X; Cai M; Wu Q; Luo D; Tang S; Luo Y
    Diabetes Obes Metab; 2012 Jul; 14(7):644-53. PubMed ID: 22340191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of pigment epithelium-derived factor delivered by adeno-associated virus inhibits blood-retinal barrier breakdown in diabetic rats.
    Yu H; Chen L; Jiang J
    Mol Vis; 2010 Nov; 16():2384-94. PubMed ID: 21139695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
    Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
    Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
    Murata T; Nakagawa K; Khalil A; Ishibashi T; Inomata H; Sueishi K
    Lab Invest; 1996 Apr; 74(4):819-25. PubMed ID: 8606491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.
    Xu X; Zhu Q; Xia X; Zhang S; Gu Q; Luo D
    Curr Eye Res; 2004 Apr; 28(4):251-6. PubMed ID: 15259294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
    Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
    Edelman JL; Lutz D; Castro MR
    Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
    Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
    Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Abdelsaid M; Siddiquei MM; Alam K; Van den Eynde K; De Hertogh G; Opdenakker G; Al-Shabrawey M; Van Damme J; Struyf S
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1956-64. PubMed ID: 25711636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy.
    Zhang X; Lai D; Bao S; Hambly BD; Gillies MC
    Curr Mol Med; 2013 Jul; 13(6):946-58. PubMed ID: 23745583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.